These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32762776)

  • 1. The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.
    Kosti A; de Araujo PR; Li WQ; Guardia GDA; Chiou J; Yi C; Ray D; Meliso F; Li YM; Delambre T; Qiao M; Burns SS; Lorbeer FK; Georgi F; Flosbach M; Klinnert S; Jenseit A; Lei X; Sandoval CR; Ha K; Zheng H; Pandey R; Gruslova A; Gupta YK; Brenner A; Kokovay E; Hughes TR; Morris QD; Galante PAF; Tiziani S; Penalva LOF
    Genome Biol; 2020 Aug; 21(1):195. PubMed ID: 32762776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
    Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
    Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.
    Bhargava S; Patil V; Mahalingam K; Somasundaram K
    Oncotarget; 2017 Mar; 8(10):16650-16668. PubMed ID: 28035070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Characterization of the RNA-Binding Protein SERBP1 Reveals Intrinsic Disorder and Atypical RNA Binding Modes.
    Baudin A; Moreno-Romero AK; Xu X; Selig EE; Penalva LOF; Libich DS
    Front Mol Biosci; 2021; 8():744707. PubMed ID: 34631798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
    Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
    Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.
    Liu Q; Liu Y; Li W; Wang X; Sawaya R; Lang FF; Yung WK; Chen K; Fuller GN; Zhang W
    Acta Neuropathol; 2015 Oct; 130(4):587-97. PubMed ID: 26323991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
    Mala U; Baral TK; Somasundaram K
    BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
    Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
    Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications.
    Roura AJ; Szadkowska P; Poleszak K; Dabrowski MJ; Ellert-Miklaszewska A; Wojnicki K; Ciechomska IA; Stepniak K; Kaminska B; Wojtas B
    Clin Epigenetics; 2023 Feb; 15(1):29. PubMed ID: 36850002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
    J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
    Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
    RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.